| Mechanisms of chemoresistance in cancer stem cells LN Abdullah, EKH Chow Clinical and translational medicine 2, 1-9, 2013 | 878 | 2013 |
| Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment EK Chow, XQ Zhang, M Chen, R Lam, E Robinson, H Huang, D Schaffer, ... Science translational medicine 3 (73), 73ra21-73ra21, 2011 | 689 | 2011 |
| Cancer nanomedicine: from drug delivery to imaging EKH Chow, D Ho Science translational medicine 5 (216), 216rv4-216rv4, 2013 | 590 | 2013 |
| Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice A Shahangian, EK Chow, X Tian, JR Kang, A Ghaffari, SY Liu, JA Belperio, ... The Journal of clinical investigation 119 (7), 1910-1920, 2009 | 590 | 2009 |
| Toll-like receptors induce a phagocytic gene program through p38 SE Doyle, RM O'Connell, GA Miranda, SA Vaidya, EK Chow, PT Liu, ... The Journal of experimental medicine 199 (1), 81-90, 2004 | 573 | 2004 |
| Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection AK Perry, EK Chow, JB Goodnough, WC Yeh, G Cheng The Journal of experimental medicine 199 (12), 1651-1658, 2004 | 488 | 2004 |
| Epigenetics in cancer stem cells TB Toh, JJ Lim, EKH Chow Molecular cancer 16, 1-20, 2017 | 448 | 2017 |
| Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges NL Syn, L Wang, EKH Chow, CT Lim, BC Goh Trends in biotechnology 35 (7), 665-676, 2017 | 411 | 2017 |
| Enabling technologies for personalized and precision medicine D Ho, SR Quake, ERB McCabe, WJ Chng, EK Chow, X Ding, BD Gelb, ... Trends in biotechnology 38 (5), 497-518, 2020 | 379 | 2020 |
| Accelerating the translation of nanomaterials in biomedicine S Mitragotri, DG Anderson, X Chen, EK Chow, D Ho, AV Kabanov, ... ACS nano 9 (7), 6644-6654, 2015 | 331 | 2015 |
| Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy XQ Zhang, R Lam, X Xu, EK Chow, HJ Kim, D Ho Advanced materials 23 (41), 4770-4775, 2011 | 297 | 2011 |
| Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine D Ho, CHK Wang, EKH Chow Science Advances 1 (7), e1500439, 2015 | 250 | 2015 |
| Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4 SE Doyle, R O’Connell, SA Vaidya, EK Chow, K Yee, G Cheng The Journal of Immunology 170 (7), 3565-3571, 2003 | 243 | 2003 |
| Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells X Wang, XC Low, W Hou, LN Abdullah, TB Toh, M Mohd Abdul Rashid, ... ACS nano 8 (12), 12151-12166, 2014 | 222 | 2014 |
| Clinical applications of carbon nanomaterials in diagnostics and therapy KP Loh, D Ho, GNC Chiu, DT Leong, G Pastorin, EKH Chow Advanced Materials 30 (47), 1802368, 2018 | 212 | 2018 |
| Nanodiamond vectors functionalized with polyethylenimine for siRNA delivery M Chen, XQ Zhang, HB Man, R Lam, EK Chow, D Ho The Journal of Physical Chemistry Letters 1 (21), 3167-3171, 2010 | 202 | 2010 |
| Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy Y Zhao, TWH Shuen, TB Toh, XY Chan, M Liu, SY Tan, Y Fan, H Yang, ... Gut 67 (10), 1845-1854, 2018 | 195 | 2018 |
| Biocompatibility assessment of detonation nanodiamond in non-human primates and rats using histological, hematologic, and urine analysis L Moore, J Yang, TTH Lan, E Osawa, DK Lee, WD Johnson, J Xi, ... ACS nano 10 (8), 7385-7400, 2016 | 145 | 2016 |
| Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression LK Moore, EK Chow, E Osawa, JM Bishop, D Ho Advanced materials (Deerfield Beach, Fla.) 25 (26), 10.1002/adma. 201300343, 2013 | 137 | 2013 |
| Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma TB Toh, JJ Lim, L Hooi, MBMA Rashid, EKH Chow Journal of hepatology 72 (1), 104-118, 2020 | 125 | 2020 |